Aspirin cost effective for secondary prevention of ischaemic events

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.282, 2000-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin plus dipyridamole effective in secondary stroke prevention

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Dipyridamole plus aspirin cost effective in stroke prevention

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Economic Assessment of the Secondary Prevention of Ischaemic Events with Lysine Acetylsalicylate

By Marissal J-P. Selke B. Lebrun T.

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 185-200

Adis International

Access to resources Recommend Favorite

Economic Assessment of the Secondary Prevention of Ischaemic Stroke with Dipyridamole plus Aspirin (Aggrenox ® /Asasantin ® ) in France

By Jean-Pierre Marissal Bernard Selke

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

Warfarin: no benefit over aspirin in ischaemic stroke prevention

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite